Seven Eight Capital’s Axonics, Inc. Common Stock AXNX Stock Holding History

Seven Eight Capital’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,830	Closed	-$395K	–	784
2023 Q2	$395K	Buy	+7,830	New	+$417K	0.07%	353
2021 Q4	–	Sell	-3,719	Closed	-$242K	–	713
2021 Q3	$242K	Buy	+3,719	New	+$254K	0.02%	521
2020 Q4	–	Sell	-30,139	Closed	-$1.54M	–	670
2020 Q3	$1.54M	Buy	+30,139	New	+$1.26M	0.33%	72

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Seven Eight Capital's AXNX Position: Q3 2023 in Review

Seven Eight Capital sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 7,830 shares — an estimated $395K sold.

Seven Eight Capital first reported a position in AXNX in Q3 2020 and held it in 3 quarters. The position peaked at $1.54M in Q3 2020. 220 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

Seven Eight Capital reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Seven Eight Capital sold 7,830 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $395K.
Seven Eight Capital first reported a position in Axonics, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
Seven Eight Capital's Axonics, Inc. Common Stock position peaked at $1.54M in Q3 2020.
220 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.